Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 5CNS 5Sarcoma 4Gastrointestinal 4Classical hematology 4Tumor-Agnostic 3Gynecologic 3Genitourinary 3Head & Neck 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Ovarian Neoplasms 2Thromboembolism 1Postoperative Hemorrhage 1Blood Loss, Surgical 1Advanced Ovarian Cancer 1

Interventions

Paclitaxel 581Carboplatin 527Cisplatin 355Bevacizumab 256pembrolizumab 226Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 126Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 90niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 73Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 56Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Tranexamic Acid × Gynecologic × Clear all
NCT06879353 2025-03-19

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

Sheikh Zayed Medical College

Phase NA Completed
372 enrolled
Gynecologic

Ovarian Neoplasms

NCT04360629 2022-06-01

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Fudan University

Phase NA Completed
151 enrolled
Gynecologic

Advanced Ovarian Cancer

NCT00740116 2022-03-15

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

University Hospital, Linkoeping

Phase 4 Completed
100 enrolled 11 charts
Gynecologic

Ovarian Neoplasms, Thromboembolism, Blood Loss, Surgical, Postoperative Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡